Psychotropic screening procedures
Authors:
- Roger D. PorsoltRPRoger D. Porsolt
- Robert A. McArthurRMRobert A. McArthur
- Antoine LenègreALAntoine Lenègre
- 1 January 1993
- book chapter
- Published by Elsevier
- p. 23-51
Abstract
No abstract availableThis publication has 105 references indexed in Scilit:
- Enhanced functional responsiveness of the dopaminergic system—the mechanism of anti-immobility effects of antidepressants in the behavioural despair test in the ratNeuropharmacology, 1988
- Behavioral pharmacology of the gamma carboline Wy 47,384: A potential antipsychotic agentDrug Development Research, 1988
- Pharmacological evaluation of HP 370, a potential atypical antipsychotic agent: 1. In vivo profileDrug Development Research, 1987
- Animal Models for Assessing Extrapyramidal-Motor Side-Effects of NeurolepticsPharmacopsychiatry, 1986
- The effects of tofisopam, a 3,4‐benzodiazepine, in animal models of anziety, sedation, and convulsionsDrug Development Research, 1986
- Animal Behavioral Models in the Discovery of Compounds To Treat Memory DysfunctionAnnals of the New York Academy of Sciences, 1985
- Pharmacological effects of HR 375: A new potential antipsychotic agentDrug Development Research, 1985
- A screening method for substances potentially active on learning and memoryJournal of Pharmacological Methods, 1982
- Changes in Behaviour with Repeated Testing under the Influence of Drugs: Drug-experience InteractionsNature, 1970
- A simple screening procedure for imipramine-like antidepressant agentsLife Sciences, 1963